Russell Investments Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.1M | Buy |
|
|||||
|
2025
Q1 | $93.1M | Buy |
|
|||||
|
2024
Q4 | $97.7M | Buy |
|
|||||
|
2024
Q3 | $136M | Buy |
|
|||||
|
2024
Q2 | $133M | Sell |
|
|||||
|
2024
Q1 | $124M | Buy |
|
|||||
|
2023
Q4 | $106M | Sell |
|
|||||
|
2023
Q3 | $104M | Buy |
|
|||||
|
2023
Q2 | $90.4M | Sell |
|
|||||
|
2023
Q1 | $105M | Sell |
|
|||||
|
2022
Q4 | $97.2M | Sell |
|
|||||
|
2022
Q3 | $115M | Buy |
|
|||||
|
2022
Q2 | $95.2M | Sell |
|
|||||
|
2022
Q1 | $131M | Sell |
|
|||||
|
2021
Q4 | $134M | Buy |
|
|||||
|
2021
Q3 | $125M | Buy |
|
|||||
|
2021
Q2 | $105M | Buy |
|
|||||
|
2021
Q1 | $77.5M | Buy |
|
|||||
|
2020
Q4 | $63.1M | Buy |
|
|||||
|
2020
Q3 | $71.4M | Sell |
|
|||||
|
2020
Q2 | $84.8M | Buy |
|
|||||
|
2020
Q1 | $58.6M | Buy |
|
|||||
|
2019
Q4 | $42.6M | Sell |
|
|||||
|
2019
Q3 | $44.1M | Buy |
|
|||||
|
2019
Q2 | $30.6M | Sell |
|
|||||
|
2019
Q1 | $48.6M | Buy |
|
|||||
|
2018
Q4 | $33.4M | Sell |
|
|||||
|
2018
Q3 | $43.1M | Buy |
|
|||||
|
2018
Q2 | $30.3M | Sell |
|
|||||
|
2018
Q1 | $62.8M | Buy |
|
|||||
|
2017
Q4 | $64.6M | Buy |
|
|||||
|
2017
Q3 | $73.6M | Buy |
|
|||||
|
2017
Q2 | $71.9M | Sell |
|
|||||
|
2017
Q1 | $60.1M | Buy |
|
|||||
|
2016
Q4 | $52.9M | Buy |
|